Katya Tsaioun

Michael Balls, Rolf Bass, Rodger Curren, et al. 60 Years of the 3Rs symposium: Lessons learned and the road ahead. Alternatives to Animal Experimentation. 2024;41(2):179-201. doi:10.14573/altex.2403061

Aldert H. Piersma, Nancy C. Baker, George P. Daston, et al. Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity. Current Research in Toxicology. 2022;3:100074. doi:10.1016/j.crtox.2022.100074

Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041

Paul Whaley, Thomas Piggott, Rebecca L. Morgan, et al. Biological plausibility in environmental health systematic reviews: a GRADE concept paper. Journal of Clinical Epidemiology. 2022;146:32-46. doi:10.1016/j.jclinepi.2022.02.011

Sebastian Hoffmann, Paul Whaley, Katya Tsaioun. How evidence-based methodologies can help identify and reduce uncertainty in chemical risk assessment. ALTEX. 2022;39(2):175-182. doi:10.14573/altex.2201131

Hubert Dirven, Gunn E. Vist, Sricharan Bandhakavi, et al. Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review. Scientific Reports. 2021;11(1):6403. doi:10.1038/s41598-021-85708-2

Thomas Hartung, Rob De Vries, Sebastian Hoffmann, et al. Toward Good In Vitro Reporting Standards. Alternatives to Animal Experimentation. 2019;36(1):3-17. doi:10.14573/altex.1812191

Kathy Archibald, Katya Tsaioun, J. Gerry Kenna, Pandora Pound. Better science for safer medicines: the human imperative. Journal of the Royal Society of Medicine. 2018;111(12):433-438. doi:10.1177/0141076818812783